The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
A major push to sharpen the future of cancer treatment is underway
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
New findings reveal bemarituzumab plus chemotherapy significantly improves survival in advanced gastric cancer, offering hope for targeted treatment options
Submission to be reviewed under FDA real-time oncology review and Project Orbis
_256_384.jpeg)
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
Subscribe To Our Newsletter & Stay Updated
